Delivery Order SPE2DB20D2014-SPE2DB25FC09X
Award Date 6/2/25
Potential Completion Date 6/3/25
Potential Value $2.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a $10,783.83 firm fixed-price delivery order for Restasis 0.05% Eye Emulsion (60 units), with an ultimate completion date of December 5, 2025. This is a competitively awarded, non-set-aside contract with performance taking place at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $6,297.40 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Restasis 0.05% eye emulsion (60-unit package). This non-set-aside, competitively awarded contract features firm fixed pricing and is scheduled for completion by July 29, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,010.08 to AmerisourceBergen Drug Corp for Restasis 0.05% Eye Emulsion (30-count packages) on December 22, 2025, with an ultimate completion date of December 23, 2025. This competitive award utilizes firm fixed pricing with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending...
- The Defense Logistics Agency awarded a $4,871.29 delivery order to AmerisourceBergen Drug Corp for Restasis 0.05% Eye Emulsion (30 single-dose units) on December 17, 2025, with an ultimate completion date of December 18, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle...
- The Defense Logistics Agency awarded a $2,256.45 delivery order to AmerisourceBergen Drug Corp for Restasis 0.05% eye emulsion (30-unit pack) on November 28, 2025, with completion targeted for December 1, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The contractor will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,705.40 to AmerisourceBergen Drug Corp for the supply of Restasis 0.05% eye emulsion (30 single-use containers) on November 12, 2025, with completion scheduled for November 13, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a small-value pharmaceutical transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued...
- The Defense Logistics Agency awarded a $1,117.68 delivery order to AmerisourceBergen Drug Corp for Restasis 0.05% eye emulsion (60 count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed price delivery order represents a non-competitive set-aside contract and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Restasis 0.05% eye emulsion in a 30-count package on April 24, 2025, with a ceiling value of $1,221.73 and a completion date of April 25, 2025. This delivery order represents a firm fixed-price, non-set-aside contract executed as a child order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The vendor, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 23, 2025, for the supply of Restasis 0.05% eye emulsion (30-count units) with a ceiling value of $1,082.16. This firm fixed-price delivery order, with an ultimate completion date of December 24, 2025, represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a $3,930.90 delivery order to AmerisourceBergen Drug Corp for Restasis 0.05% Eye Emulsion (30 single-dose units) on December 19, 2025, with an ultimate completion date of December 22, 2025. This is a firm fixed-price, non-set-aside contract issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to...